| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.007 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.007 |